[1]
PrzybyƂ, M. et al. 2026. Suzetrigine in the Management of Pain Review of the First-in-class Na V1.8 Selective Inhibitor. Journal of Education, Health and Sport. 90, (Apr. 2026), 70122. DOI:https://doi.org/10.12775/JEHS.2026.90.70122.